Pharmaceuticals & Biotechnology

By Jim Sabogal | Using #clinicaltrials to make #medicines for #pharma and #biotech

The World May Soon Run Out of Antibiotics

Antibiotic-resistant infections are a growing problem, and there is not enough research currently underway to develop new drugs.

Medicine

Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag

Big Pharma’s businesses in emerging markets grew 6.1% sequentially in the second quarter, the fastest in more than two years, according to a recent …

Economy

This Startup Is Bringing a $40 Billion Market Out of the Stone Age

This paper-based industry is long overdue for a digital overhaul.<p>While much of the research and development conducted by the global pharmaceutical industry relies on cutting edge technology, one aspect of the process of developing and testing new drugs is decidedly low tech: clinical …

Clinical Trials

Alexion's Growth Appears Dead

ALXN announced it was restructuring its business and moving its headquarters from New Haven, CT to Boston.<p>Sales in the second half of 2017 could …

Stocks

Why Amgen, Lilly, J&J Are Interested In These Small Biotechs

<b>Theravance Biopharma</b> (TBPH) and <b>Exelixis</b> (EXEL) tick off most of the acquisition boxes for Big Pharma in an overview of the biotech merger picture, an …

Stocks

The Biotech Revolution Comes To Fruition For Investors

It took well over a decade and $1 billion to map the first genome. Now, it can be done in a few days for a few thousand dollars. As a result, entirely new classes of drugs are under development to combat a variety of diseases for which no effective treatments exist. A revolution in biotech is …

Stocks

Why Drugs Cost Less in the U.K. Than in the U.S.: QuickTake Q&A

Drug prices in the U.K., already among the lowest in the developed world, may drop lower still. The British public-health system has adopted new …

Pharma

How To Improve Precision Medicine With Machine Learning

This column is authored by Computer Science student, Awais Ali<p>Photo by Hal Gatewood on Unsplash<p>Machine learning can be the difference between life …

Machine Learning

A Serious Reaction After Vaccination Rarely Occurs Again With Later Immunization, Study Finds

A child who experiences a serious medical event after a vaccine has a very low risk of having another serious event occur after the next vaccine, found a new study. Milder reactions, such as fevers, swelling, pain, sleepiness, decreased appetite, vomiting or persistent crying, re-occurred in 4% to …

Medicine

A first: Drug lowers heart risks by curbing inflammation

For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years.<p>People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an …

Medicine

Cancer drugs that halt tumors can also shrink them

A class of drugs known as CDK4/6 inhibitors, which have been approved for treating some types of breast cancer, may have much more to offer than …

What’s Harder Than Making Copycat Biotech Drugs? Selling Them

Big-name drugmakers want to profit from selling lower-priced copies of rivals’ expensive biotechnology drugs. Patients and doctors want to pay less …

The Startling History Behind Merck's New Cancer Blockbuster

No area is hotter or attracting more dollars in pharma than immuno-oncology–the idea of harnessing the immune system to fight cancer. My fellow Forbes contributor Bruce Booth has recently characterized the intensifying interest in this space as the “exploding supernova” of cancer research.<p>Few …

Cancer

These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet -- The Motley Fool

Biogen, Johnson & Johnson, Lilly, AbbVie, and Celgene could have huge winners on their hands in the near future.<p>$45 billion for five experimental …

GlaxoSmithKline Takes Drug Discovery To The Next Level

Big data could be the future of the new antibiotic in the health care industry to enhance the patient medical care. Big data is shifting the paradigm …

Here's how the CEO of a $50 billion drugmaker sees tech companies 'disrupting' healthcare

• <b>Big technology companies are getting more interested in healthcare.</b>• <b><br>Whether those companies will be able to "disrupt" the industry remains to be seen.</b>• <b><br>Shire CEO Flemming Ornskov said he sees tech companies that play off their existing strengths coming out ahead.</b><p>Major tech companies have been eyeing …

Digital Health

5 Big Pharma Stocks With the Best Drug Pipelines -- The Motley Fool

Billions of dollars could be made over the next few years from these top big pharma pipelines.<p>Big pharma companies can't rest on their laurels. …

A new view of twisted proteins could help scientists understand Alzheimer's

A critical molecule in the neurodegenerative disease has finally been mapped.<p>A new study published this month in <i>Nature</i> marks a key milestone in Alzheimer's research. It demonstrates the first complete model of a tau filament, a protein structure found in the brain cells of Alzheimer's patients and …

Alzheimer's Disease

Seniors miss out on clinical trials

Why are a disproportionately low number of senior citizens participating in studies?<p>More than 60 percent of cancer patients are older adults — and that will rise to 70 percent by 2040. Yet seniors continue to be underrepresented in clinical trials, making it difficult to assess how treatments are …

Medicine

Big pharma turns to AI to speed drug discovery, GSK signs deal

LONDON (Reuters) - The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.<p>Other pharmaceutical giants including Merck & Co, Johnson & …

Pharma

People Are Not Petri Dishes -- A New Study Shows Why Antibiotics Fail

Picking the right antibiotic, especially for a seriously ill patient, is increasingly difficult because of the growing problem of antibiotic resistance.<p>Bacteria growing on Mueller-Hinton media in a petri dish. Clear areas around discs of antibiotics show which drugs are relatively effective.<p>Doctors …

Medicine

How Trump Can Curb Runaway Drug Prices

The president could use his deal-making skills to negotiate voluntary pricing restraints for the industry.<p>The affordability of prescription drugs is a growing public concern, as annual drug spending continues to rise year after year. Recent pricing scandals, including the 6,000 percent increase in …

Pharma

The Supreme Court Just Made a Big Opportunity for Biosimilars Even Bigger -- The Motley Fool

Biosimilars could be the next big thing in biotech, and thanks to a recent Supreme Court decision, biosimilar drug developers could reap billions of …

Pharma

Doctors Call On Big Pharma To Advertise Retail Prices Of Prescription Drugs

Think of the last prescription you had filled: You probably know how much you had to pay the pharmacy, but do you have any idea of the full sticker …

Pharma

New Data Shows TG Therapeutics Could Be Onto Something Big -- The Motley Fool

Trial results for blood cancer drugs in TG Therapeutics' pipeline could one day change how patients with advanced disease are treated.<p><b>TG Therapeutics</b> …

Stocks

Trump administration preparing executive order on drug pricing

The Trump administration is preparing an executive order aimed at lowering drug prices, according to sources familiar with the process.President …

Mick Mulvaney

A physician wades into the swamp of vaccine denial

I occasionally dip my toe into the constant Internet flame wars over the generous term “vaccine skepticism,” and the less generous “vaccine …

Health Care

Brain Cells From Pigs Implanted Into Human Brains to Treat Parkinson's

Neurochemical Reboot<p>New Zealand biotech company Living Cell Technologies has developed a treatment for Parkinson’s disease using choroid plexus cells …

Medicine

New frontier in cancer care: Turning blood into living drugs

SEATTLE (AP) — Ken Shefveland's body was swollen with cancer, treatment after treatment failing until doctors gambled on a radical approach: They removed some of his immune cells, engineered them into cancer assassins and unleashed them into his bloodstream.<p>Immune therapy is the hottest trend in …

Cancer